Mereo BioPharma Group (MREO)
NASDAQ: MREO
· Real-Time Price · USD
2.48
0.09 (3.77%)
At close: May 08, 2025, 12:36 PM
3.77% (1D)
| Bid | 1.75 |
| Market Cap | 385.54M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -43.25M |
| EPS (ttm) | -0.3 |
| PE Ratio (ttm) | -8.28 |
| Forward PE | -116.5 |
| Analyst | Buy |
| Ask | 2.49 |
| Volume | 407,160 |
| Avg. Volume (20D) | 1,492,493 |
| Open | 2.34 |
| Previous Close | 2.39 |
| Day's Range | 2.29 - 2.48 |
| 52-Week Range | 1.57 - 5.02 |
| Beta | 0.47 |
About MREO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MREO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MREO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Mereo BioPharma Group is scheduled to release its earnings on May 19, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+1.69%
Mereo BioPharma shares are trading higher after JP...
Unlock content with
Pro Subscription
5 months ago
+8.65%
Mereo BioPharma shares are trading higher after Jeffereis initiated coverage on the stock with a Buy rating and $7 price target.
